Home/Filings/4/0001209191-23-048184
4//SEC Filing

Huennekens R Scott 4

Accession 0001209191-23-048184

CIK 0001142596other

Filed

Sep 4, 8:00 PM ET

Accepted

Sep 5, 4:52 PM ET

Size

16.7 KB

Accession

0001209191-23-048184

Insider Transaction Report

Form 4
Period: 2023-09-01
Transactions
  • Disposition to Issuer

    Restricted Stock Unit

    2023-09-014,8160 total
    Common Stock (4,816 underlying)
  • Disposition to Issuer

    Restricted Stock Unit

    2023-09-013,0950 total
    Common Stock (3,095 underlying)
  • Disposition to Issuer

    Common Stock, par value $0.001 per share

    2023-09-011,3600 total
  • Disposition to Issuer

    Restricted Stock Unit

    2023-09-012,7020 total
    Common Stock (2,702 underlying)
  • Disposition to Issuer

    Restricted Stock Unit

    2023-09-012,5770 total
    Common Stock (2,577 underlying)
  • Disposition to Issuer

    Restricted Stock Unit

    2023-09-013,7880 total
    Common Stock (3,788 underlying)
Footnotes (3)
  • [F1]Pursuant to the Agreement and Plan of Merger, dated as of February 8, 2023 (the "Merger Agreement"), by and among the Issuer, Globus Medical, Inc. ("Globus") and Zebra Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer, with the Issuer continuing as a wholly owned subsidiary of Globus. At the effective time of the merger (the "Effective Time"), each share of the Issuer's common stock issued and outstanding immediately prior to the Effective Time (other than certain excluded shares) was cancelled and converted into the right to receive 0.75 shares of Class A common stock of Globus ("Globus Class A Common Stock"), par value $0.001 per share (the "Exchange Ratio" and such shares, the "Merger Consideration"), and cash in lieu of fractional shares.
  • [F2]Represented a contingent right to receive one share of the Issuer's common stock upon vesting.
  • [F3]Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award became fully vested and was cancelled and converted automatically into the right to receive (without interest) the Merger Consideration in respect of each share of Issuer common stock underlying such award.

Issuer

NUVASIVE INC

CIK 0001142596

Entity typeother

Related Parties

1
  • filerCIK 0001365493

Filing Metadata

Form type
4
Filed
Sep 4, 8:00 PM ET
Accepted
Sep 5, 4:52 PM ET
Size
16.7 KB